• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Journal Scan: Tackling feline eosinophilic plaques with antibiotics

April 2, 2012
Avi Blake, DVM

A recent study evaluated naturally occurring feline eosinophilic plaques and lip ulcers for secondary infections and to determine the response to antibiotic therapy.

Feline eosinophilic plaques and lip ulcers are representative of a common clinical skin reaction seen in cats termed eosinophilic granuloma complex. As these lesions are prone to erosion and ulceration, secondary bacterial infections are common and likely result in worsening of the lesions.

What they did

The aim of a recent study was to evaluate naturally occurring feline eosinophilic plaques and lip ulcers for secondary infections and to determine the response to antibiotic therapy. By culturing and performing antibiotic susceptibility testing from representative lesions and measuring the lesions before and after antibiotic therapy, the researchers hoped to determine the clinical usefulness of this treatment option. Amoxicillin trihydrate-clavulanate potassium was selected because of its broad-spectrum antimicrobial activity and its efficacy against the normal flora common in feline inflammatory lesions.

Sixteen healthy client-owned cats with confirmed eosinophilic plaques or lip ulcers (nine with plaques and eight with lip ulcers) completed the study. All of the cats had a history of a static condition or a worsening of the condition over several weeks and no history of spontaneous regression of their lesions.

On the first day of the study, a superficial impression smear was examined, and swabs were obtained for aerobic cultures. The cats with each type of lesion were randomly divided into treatment and placebo groups. The cats received a 21-day course of either amoxicillin-clavulanate or placebo. Digital photographs and measurements of the lesions were taken on days 1 and 21 of treatment. On day 21, the cats were reexamined, and a second impression smear of the lesion or previously affected area was taken. There were no adverse reactions to the therapy reported.

What they found


Advertisement

All of the cats' lesions were found to be infected. Coagulase-positive staphylococci were the most frequent isolates.

The cats with eosinophilic plaques responded well to the antibiotic therapy, resulting in a 96.2% reduction in lesion size and an 80% reduction in the microscopic demonstration of bacterial infection. No improvement in these parameters was documented in the placebo group.

The cats with lip ulcers saw a 65% reduction in microscopically identified infection as compared with the placebo group, where no reduction was observed. However, while there was a modest reduction in lip ulcer lesion size for treated cats, as compared with an increase in lesion size for untreated cats, the change was not statistically significant. This disparity in results based on lesion type is not explained in the study design, but the authors hypothesize that increased dosage or treatment duration may be necessary to successfully treat lip ulcers.

Take-home message

The use of amoxicillin-clavulanate was demonstrated to be safe and effective for addressing the secondary bacterial infections associated with feline eosinophilic plaques. These findings substantiate the practice of treating the bacterial infection associated with feline eosinophilic plaques while also addressing the underlying condition.

Wildermuth BE, Griffin CE, Rosenkrantz WS. Response of feline eosinophilic plaques and lip ulcers to amoxicillin trihydrate-clavulanate potassium therapy: a randomized, double-blind placebo-controlled prospective study. Vet Dermatol 2012;23(2):100-e25.

Link to abstract: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3164.2011.01020.x/abstract

Related Content:

DermatologyFeline Medicine
Dermatology expert explains the PSPP system when dealing with ear disease
Dermatology expert explains the PSPP system when dealing with ear disease
FDA approves generic drug for managing allergic dermatitis in cats
FDA approves generic drug for managing allergic dermatitis in cats
Chronic feline pain from all perspectives
Chronic feline pain from all perspectives

Advertisement

Latest News

Morris Animal Foundation appoints new chief program officer

CDC issues warning over cat-transmitted sporotrichosis

An AI solution is speeding up insurance claims processing

3 categories of inappetence in dogs

View More Latest News
Advertisement